Cybin Inc. CYBN announced that it has received a received a "may proceed letter" and a clearance of the investigational new drug ("IND") application from the FDA to begin a phase I/IIa study ...

Concordia's IT technicians will be making an upgrade available to all MDD users through the use of the Software Center. This upgrade is both a standalone product that can be installed without a prior ...

Jefferies analyst Andrew Tsai has maintained their bullish stance on XENE stock, giving a Buy rating on December 7. Andrew Tsai of Jefferies has given Xenon’s stock a Buy rating, influenced by a ...

--Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’ s disease, bipolar disorder, major depressive disorder and ...

People with major depressive disorder (MDD) feel more negative emotion when remembering painful experiences than people without the disorder, according to a new study in Biological Psychiatry ...

Major depressive disorder (MDD) is not only among the most common mental illnesses, affecting over 8% of Americans, but it is also extremely variable from one person to another. Skip to content Menu ...